2023年3月23日,

分享Synaptive的上一代机器人exoscope一直在成千上万的手术临床验证。它使外科医生进行微创的方法,提供了更好的人体工程学无痛手术的经验。方法X,下一代提供先进的4 k 3 d光学和荧光模式来提高神经外科手术可视化,ENT、塑料和脊柱。Synaptive医疗、全球医疗技术创新者,宣布FDA注册的下一代机器人exoscope。方法X是Synaptive备受期待的第四代的机器人exoscope,交付一个飞跃在光学性能和机器人技术现代化手术室。方法X功能重新设计4 k 3 d光学、27 X放大,图像自动聚焦、语音指导等等。创新平台还支持fluorescence-guided手术实时提高肿瘤组织分化。此外,灵活的设计方法X允许现场升级方法V, Synaptive第三代exoscope目前安装在全球80家医院。"我们预期这些增强可视化功能将使外科医生执行更加有效和精确的干预他们的病人的利益,”卡梅伦Piron称,总统和Synaptive医学的创始人之一。“通过多年的跨学科合作与我们的临床合作伙伴,我们已经来到这个终极平台推动外科可视化的界限。” Modus X is part of Synaptive’s integrated suite of products, connecting clinicians in operating rooms across mid-field MRI, surgical planning and navigation, and surgical visualization. Synaptive’s devices are designed to automate critical patient data through every step of surgical intervention to improve clinical decision-making. Synaptive will be featuring Modus X and offering demonstrations at several upcoming meetings including: American Association of Neurological Surgeons (AANS): April 21 – 24, 2023 in Los Angeles, CA, with Dr. Costas Hadjipanayis to present on early experience on April 22nd. Congress of Neurological Surgeons (CNS): September 9 – 13, 2023 in Washington, DC. Synaptive Medical Inc., a Toronto-based, high growth global medical technology company, solves surgical, imaging, and data challenges to improve the quality of human lives. Synaptive’s integrated suite of products – bridging MRI, surgical planning, navigation, and robotic visualization – delivers patient-centric information with automated efficiency across all stages of clinical interventions.